Saffron vs Ashwagandha: Which Is Better for Stress and Mood?

What Saffron Actually Does for Mood

Saffron is the dried stigma of Crocus sativus, and its mood effects trace to two compounds: crocin, the pigment that makes it red-gold, and safranal, which gives it the smell. Both influence serotonergic signaling, meaning saffron appears to slow the reuptake of serotonin and let your brain keep more of what it makes. That is the same general pathway as SSRI antidepressants, which is why the head-to-head trials exist at all.

Those trials are more interesting than most people expect. In 2004, Akhondzadeh and colleagues published a double-blind trial in Phytotherapy Research: 40 adults with mild to moderate depression took either 30 mg of saffron or 20 mg of fluoxetine daily for six weeks. The saffron group improved as much as the fluoxetine group on the Hamilton Depression Rating Scale. A year later, the same research group ran it back in BMC Complementary and Alternative Medicine, this time against imipramine 100 mg daily, with the same result: comparable improvement over six weeks.

A 2016 meta-analysis by Mazidi and colleagues in the Journal of Integrative Medicine pooled the randomized trials and concluded saffron was significantly better than placebo and statistically comparable to antidepressant medication for mild to moderate depression. I want to be precise about what that means. These were small trials, mostly out of Iran, where saffron research is a point of national pride. The effect sizes are real and consistent, but the total evidence base is measured in hundreds of patients, not tens of thousands. And none of this makes saffron a treatment for depression. If you are dealing with diagnosed depression, that is a doctor conversation, not a supplement decision.

For the rest of us, the people with low-grade flatness rather than a diagnosis, the modern extract trials are the relevant ones. Lopresti and colleagues ran a 2018 trial in Complementary Therapies in Medicine using Affron, a standardized saffron extract, at 28 mg per day for four weeks in adults with self-reported low mood. Mood scores improved significantly versus placebo. The same group published a 2020 trial in the Journal of Clinical Sleep Medicine showing 28 mg daily improved sleep quality ratings over 28 days in adults with poor sleep, which matters because sleep and mood prop each other up.

One more saffron evidence lane deserves mention because it surprises people: PMS mood symptoms. Several trials, including work by Agha-Hosseini and colleagues published in BJOG in 2008, found saffron significantly reduced premenstrual mood and symptom scores compared to placebo. If your low mood runs on a monthly cycle, that is the herb with direct data on your exact pattern.

Our saffron extract is standardized to the crocin and safranal content the trials actually used, which is the part most grocery-aisle saffron products skip. The full evidence walk, study by study, is in our saffron for mood review.

What Saffron Actually Does for Mood

What Ashwagandha Actually Does for Stress

Ashwagandha, Withania somnifera, is a different animal entirely. It is an adaptogen, and its active compounds, the withanolides, work mainly on the hypothalamic-pituitary-adrenal axis, the command chain that governs your cortisol output. Saffron adjusts how your brain handles serotonin. Ashwagandha turns down the volume on the stress response itself.

The trial everyone cites deserves the attention. Chandrasekhar and colleagues published it in the Indian Journal of Psychological Medicine in 2012: 64 adults with chronic stress took 300 mg of KSM-66 ashwagandha root extract twice daily for 60 days. Cortisol dropped 27.9 percent versus a trivial change on placebo, and perceived stress scores fell 44 percent. Those are unusually clean numbers for a botanical trial.

The finding has replicated. Salve and colleagues ran an eight-week trial in Cureus in 2019 with 250 to 600 mg daily and found cortisol reductions in the same 23 to 30 percent band, plus better sleep quality. Lopresti’s group published a 2019 trial in Medicine using 240 mg of a high-concentration extract daily for 60 days and saw both cortisol and DHEA-S come down alongside anxiety scores. A 2022 meta-analysis in Phytotherapy Research pooling 12 randomized trials and over 1,000 participants found significant benefits on both stress and anxiety measures.

Where ashwagandha is weaker is mood itself. The trials show it helps anxiety and perceived stress, but the data on lifting low mood directly is thinner and less consistent than saffron’s. One extra detail worth knowing: the Lopresti 2019 trial also tracked DHEA-S, a hormone that typically climbs with chronic stress, and found it came down alongside cortisol. That is a second, independent signal that the HPA axis genuinely quiets down rather than the effect being a single-marker fluke. Sleep is the other reliable secondary benefit: in the Salve trial, the ashwagandha group reported meaningfully better sleep quality, which fits the mechanism, since elevated evening cortisol is one of the classic drivers of lying awake with a racing mind.

If your core complaint is emotional flatness rather than a revved-up stress system, ashwagandha is the blunter instrument. Our ashwagandha extract uses the concentrated root form matching the clinical doses, and the full benefits and dosage breakdown is in our ashwagandha guide.

What Ashwagandha Actually Does for Stress

Saffron vs Ashwagandha: The Evidence Side by Side

Put the two evidence bases next to each other and the pattern is clear:

Two practical readings fall out of this table. First, the onset difference matters for expectations: saffron’s mood trials show separation from placebo within a month, while ashwagandha’s cortisol effects need six to eight weeks of consistent dosing before you judge them. Second, “which is better” is the wrong frame. They answer different questions. The right frame is which problem you actually have.

Saffron vs Ashwagandha: The Evidence Side by Side

Which One Fits Your Situation

Here is the decision framework I would use.

Choose saffron if your stress shows up emotionally. You are irritable, reactive, flat, or low. Small things land harder than they should. Your sleep is okay-ish but your mood drags. You want something with direct human evidence on emotional wellbeing and a side effect profile that, at 28 to 30 mg, looks a lot like placebo in the trials.

Choose ashwagandha if your stress shows up physically. You are wired at night and tired in the morning. You carry tension in your shoulders and jaw. You suspect, or a lab has told you, that your cortisol runs high. You train hard and want recovery support alongside stress support. You can commit to eight weeks before judging it.

Choose both if you recognize yourself in both paragraphs, which describes a lot of people. More on that in a moment.

One honest note on expectations: neither of these touches the sources of stress. If the problem is a job, a relationship, or a mortgage, no capsule fixes that. What the evidence supports is a meaningful nudge to the system that processes the stress, and for many people that nudge is the difference between coping and not coping.

There is also a timing angle most comparisons miss. Saffron’s trials dosed once or twice daily with no strong chronobiology signal, so take it whenever you will remember it. Ashwagandha has a mild calming, sleep-supportive effect in the trials, so evening dosing makes practical sense, and the Salve trial’s sleep improvements fit that pattern. If you end up running both, the natural split is saffron with breakfast and ashwagandha with dinner.

Which One Fits Your Situation

Side Effects and Safety: Where They Really Differ

This is the section most comparison articles phone in, and it is where the two herbs genuinely separate.

Saffron at 28 to 30 mg daily has one of the cleanest safety records in the supplement literature. Across the mood trials, side effects like mild nausea or headache occurred at roughly placebo rates, and studies running up to 26 weeks found no concerning signals. Two cautions do apply. Very high doses, meaning grams rather than milligrams, are genuinely toxic, but that is roughly 170 times the supplement dose and not a realistic exposure from a standardized product. And saffron has a traditional use as a uterine stimulant at high doses, so pregnant women should stick to culinary amounts and skip concentrated supplements. Anyone with bipolar disorder should also talk to their psychiatrist first, since any serotonergic agent carries a theoretical activation risk.

Ashwagandha is well tolerated by most people at 300 to 600 mg daily for up to about three months, which is where the trial data runs out. Beyond that window the safety data gets thin, and three specific issues deserve respect. First, ashwagandha can stimulate thyroid activity, so anyone with hyperthyroidism or on thyroid medication should clear it with their doctor. Second, published case reports, including a 2020 case series describing five patients, link ashwagandha to rare liver injury; it is uncommon, but it is documented, and anyone with existing liver issues should factor that in. Third, a growing number of users report emotional blunting with long-term use: the stress response turns down so far that normal emotional range goes with it. It is anecdotal rather than trial-proven, but the reports are consistent enough that I take planned breaks after eight to twelve weeks rather than running it indefinitely. For a fuller interaction picture, our saffron drug interactions article covers the medication specifics.

Can You Take Saffron and Ashwagandha Together?

Yes, and there is actual data behind the combination rather than just logic. The logic is sound: saffron works on serotonin, ashwagandha works on cortisol, and the two pathways do not compete. There is no known pharmacokinetic interaction between them at standard doses.

The data point is a 2024 trial by Pages-García and colleagues, which tested a combination of saffron, ashwagandha, tryptophan, and vitamin B6 and found improvements in anxiety measures and health-related quality of life. It was a formula trial rather than a two-ingredient isolation, so it cannot tell us exactly how much each component contributed, but it confirms the combination is well tolerated and moves the outcomes people care about.

If you want to run the pairing, the sane way to do it is sequentially, not simultaneously. Start one, give it two to three weeks, then add the second. If you start both on the same day and feel great, you will never know which one is doing the work. And if you feel off, you will not know which one to drop. Standard dosing for the combination: 28 to 30 mg saffron extract with breakfast, 300 to 600 mg ashwagandha root extract with dinner, since its calming effect pairs naturally with the evening.

The Cost and Quality Question

These two herbs sit at opposite ends of the supplement-quality problem, and it affects which product you buy more than which herb you choose.

Saffron is the most adulterated spice on earth. Real saffron costs more per gram than silver, so the incentive to fake it is enormous: dyed corn silk, safflower petals, and exhausted threads re-colored with artificial dye all show up in the supply chain. A supplement that just says “saffron” on the label with no standardization is a coin flip. What you want is an extract standardized to crocin and safranal content, because those are the compounds the trials measured. Our saffron real vs fake guide shows the lab markers that separate genuine extract from dressed-up filler, and it applies to any brand you are considering.

Ashwagandha’s problem is different: not fakery but potency spread. Plain root powder can run under 0.3 percent withanolides, while standardized extracts like KSM-66 or high-concentration root extracts run 5 percent or more. The trials that moved cortisol used the standardized forms. A cheap powder capsule at the same milligram count can deliver a tenth of the active compounds, which is one reason some people try ashwagandha, feel nothing, and write it off. Check the label for withanolide standardization before you judge the herb.

Either way, this is the part of the saffron vs ashwagandha decision that the comparison articles skip: the herb choice matters less than buying the form the research actually used.

Who Should Skip One or Both

• Pregnant or breastfeeding women. Saffron supplements are out at concentrated doses, and ashwagandha lacks adequate pregnancy safety data.
• Anyone with hyperthyroidism or on thyroid medication. Ashwagandha’s thyroid-stimulating effect is real.
• People with liver conditions. The rare ashwagandha liver injury reports make this a doctor-first conversation.
• Anyone with bipolar disorder. Saffron’s serotonergic activity carries a theoretical activation risk.
• People on sedatives, immunosuppressants, or blood sugar medication. Ashwagandha can amplify or interfere.
• Anyone with diagnosed depression or an anxiety disorder. These trials studied mild to moderate, self-reported symptoms. A diagnosis belongs with a clinician, and supplements are an adjunct conversation to have with them, not a replacement for care.

Frequently Asked Questions

MD, PhD

Dr. Dimitar Marinov

Medical Reviewer • Chief Assistant Professor, Medical University of Varna

Dr. Marinov is a licensed physician and scientist specializing in nutrition and dietetics with years of experience in clinical and preventive medicine. He references every statement with high-quality research.

LinkedIn Instagram Google Scholar ResearchGate Website